Monte Rosa Therapeutics PEG

PEG Ratio (Price/Earnings-to-Growth) of Monte Rosa Therapeutics is -0.87 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of Monte Rosa Therapeutics changed from -0.46 to -0.87, representing a 89.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Monte Rosa Therapeutics since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Monte Rosa Therapeutics with sector peers and the industry average to assess whether it is attractive.